The estimated Net Worth of Josep Llorens is at least $3.52 Milhão dollars as of 17 May 2024. Mr. Llorens owns over 1,809 units of Haemonetics stock worth over $1,543,910 and over the last 6 years he sold HAE stock worth over $395,640. In addition, he makes $1,576,130 as Senior Vice President - Global Manufacturing and Supply Chain at Haemonetics.
Josep has made over 13 trades of the Haemonetics stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 1,809 units of HAE stock worth $171,783 on 17 May 2024.
The largest trade he's ever made was exercising 4,928 units of Haemonetics stock on 18 July 2023 worth over $281,389. On average, Josep trades about 641 units every 90 days since 2018. As of 17 May 2024 he still owns at least 21,310 units of Haemonetics stock.
You can see the complete history of Mr. Llorens stock trades at the bottom of the page.
Josep L. Llorens serves as Senior Vice President - Global Manufacturing and Supply Chain of the Company. Mr. Llorens possesses over 30 years of experience in leading numerous turnarounds in global health care and consumer businesses across disposables, capital equipment, devices and software. Prior to joining the Company, Mr. Llorens held various operations and supply chain roles of increasing responsibility within the diagnostics and treatment, patient monitoring and cardiac care business of Philips, which he joined in 1992, most recently serving as Senior Vice President, Industrial Strategy and Advanced Manufacturing Engineering Leader for Phillips Healthcare Diagnostic Imaging from January 2018 to August 2018. Mr. Llorens received a bachelor’s degree in Business Administration from the University of Barcelona and a master’s degree in Telecommunications Engineering from the Polytechnic University of Catalonia in Barcelona. He also holds an Executive Certificate in Technology, Operations and Value Chain Management from the MIT Sloan School of Management.
As the Senior Vice President - Global Manufacturing and Supply Chain of Haemonetics, the total compensation of Josep Llorens at Haemonetics is $1,576,130. There are 3 executives at Haemonetics getting paid more, with Christopher Simon having the highest compensation of $9,398,200.
Josep Llorens is 58, he's been the Senior Vice President - Global Manufacturing and Supply Chain of Haemonetics since 2018. There are 7 older and 5 younger executives at Haemonetics. The oldest executive at Haemonetics Corp. is Richard Meelia, 71, who is the Independent Chairman of the Board.
Over the last 21 years, insiders at Haemonetics have traded over $82,114,016 worth of Haemonetics stock and bought 334,931 units worth $14,646,550 . The most active insiders traders include Paul Black, Robert E Abernathy, eBrad Nutter. On average, Haemonetics executives and independent directors trade stock every 13 days with the average trade being worth of $539,753. The most recent stock trade was executed by Stewart W Strong on 26 July 2024, trading 4,312 units of HAE stock currently worth $393,039.
haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right
Haemonetics executives and other stock owners filed with the SEC include: